All posts by: Maya Yoshida-Cervantes

The introduction of Hepatitis C Direct Acting Agents (DAA’s) has significantly altered the treatment paradigm.  The combination of improved sustained viral response (SVR) rates, minimal...
Continue Reading →
  Hepatitis C is a chronic condition for which a cure exists, but at a cost that is so high it often creates barriers to...
Continue Reading →